Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 16/20 | 0.45 |
| ▸ | MAOA | P21397 | 4/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30065877 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CYP3A4HPGDMAPK1MAOB | |
| SCHEMBL4119366 | 0.90 | MAOB (0.40) | ALDH1A1CYP3A4HPGDMAPK1MAOB | |
| SCHEMBL30113210 | 0.88 | MEN1 (0.46) | ALDH1A1CYP3A4MAOB | |
| SCHEMBL18796518 | 0.88 | MEN1 (0.46) | ALDH1A1CYP3A4MAOB | |
| SCHEMBL30113113 | 0.87 | CA12 (0.49) | ALDH1A1CYP3A4HPGDMAPK1 | |
| SCHEMBL18796365 | 0.87 | CA12 (0.49) | ALDH1A1CYP3A4HPGDMAPK1 | |
| SCHEMBL5618972 | 0.87 | MEN1 (0.43) | ALDH1A1HPGD | |
| SCHEMBL3685410 | 0.86 | MAOB (0.43) | MAOBMAOA | |
| SCHEMBL27445640 | 0.86 | HSD11B1 (0.41) | ALDH1A1CYP3A4HPGDMAPK1 | |
| SCHEMBL6908438 | 0.84 | GAA (0.41) | CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250042911-A1 | NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF | SPARK BIOPHARMA, INC. (KR) | 2025-02-06 | — | — | US | disclosed |
| EP-4365175-A1 | NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF | Spark Biopharma, Inc. (KR) | 2024-05-08 | — | — | EP | disclosed |
| CN-117897386-A | Benzopyran derivatives and uses thereof | 斯帕克生物制药有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20230125487-A1 | COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY BOWEL DISEASE | FUGENBIO CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20160130394-A1 | ISOFLAVONE-BASED POLYMER, LENS AND CAMERA MODULE USING THE SAME | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2016-05-12 | — | — | US | disclosed |
| US-20160130394-A1 | ISOFLAVONE-BASED POLYMER, LENS AND CAMERA MODULE USING THE SAME | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2016-05-12 | — | — | US | disclosed |
| EP-2253226-B1 | Use of hydroxyflavone derivatives for modifying taste | LEIBNIZ INST FÜR PFLANZENBIOCHEMIE IPB (DE) | 2015-07-15 | — | — | EP | disclosed |
| EP-2253226-A1 | Use of hydroxyflavone derivatives for modifying taste | Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) | 2010-11-24 | — | — | EP | disclosed |
| US-20100292175-A1 | USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION | Leibniz-Institut fur Pflanzenbiochemie (DE) | 2010-11-18 | — | — | US | disclosed |
| WO-2009026658-A1 | PPAR AGONISTS | THE UNIVERSITY OF SYDNEY (AU) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009026657-A1 | FLAVONOID PPAR AGONISTS | THE UNIVERSITY OF SYDNEY (AU) | 2009-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230125487-A1 | COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY BOWEL DISEASE | SLC10A2, SI, FABP2 | ALDH1A1 2671/4885CYP3A4 4320/4885HPGD 727/4885 |
| US-20250042911-A1 | NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF | MYD88, MYADM, CD14 | ALDH1A1 2146/4885CYP3A4 428/4885HPGD 229/4885 |
| US-20100292175-A1 | USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION | TAS2R50, TAS2R60, TAS2R30 | ALDH1A1 450/4885CYP3A4 1777/4885HPGD 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.